NCT06568627Phase 3Recruiting

A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE)

Study sponsor: MediWound Ltd · MDWD

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-12Estimated
Enrollment · participants216Estimated
Source updated2026-10-09Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Main study measure wording changed

Text changed; whether the study measures changed has not been verified. Saved text may be shortened.

Before: Measure: Incidence of complete debridement, clinically (visually) assessed after each application Measure: Incidence of complete wound closure. After: Measure: Incidence of complete debridement, clinically (visually) assessed after each application Measure: Facilitation of wound closure, clinically assessed, as measured by time to complete wound closure.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview